Sweden has surpassed the UNAIDS 95-95-95 targets, with reduced HIV incidence and a steady increase in diagnosed and treated cases. However, challenges remain, especially among migrant populations and recent arrivals.
Medeor’s cell therapy boosts immune tolerance in registrational trial of donor kidney recipients
Medeor Therapeutics’ Phase III single-dose cell therapy has seen more than half of a specific group of donor kidney recipients stop immunosuppression therapy for two
November 3, 2023